Clinical Trials Directory

Trials / Unknown

UnknownNCT02385370

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method

Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Patients with advanced glaucoma that are candidates for trabeculectomy will be included. Thorough ophthalmic examination including best corrected visual acuity, slit lamp examination, intraocular pressure (IOP) measurement, gonioscopy, funduscopy and specularly microscopy will be performed for all participants. Patients will be assigned randomly to 2 groups. In one group they will undergo fornix based trabeculectomy with conventional MMC 0.02% soaked sponges application. In the other group 0.1 cc of 0.01 MMC will be injected into the tenon at the beginning of the surgery. The rest of the operation is the same for both groups as standard trabeculectomy. Ophthalmic examination including IOP measurement will be performed at one, 3 and 6th month post surgery. Specular microscopy will be requested at final follow up visit. Bleb morphology will be scored according to Indian grading system at 3rd and 6th months post surgery.

Conditions

Interventions

TypeNameDescription
DRUGMMCusing 0.02 MMC soaked sponged under the conjunctiva for 1 to 3 minutes
DRUGMMC0.1 cc of 0.01% MMC is injected into the tenon.

Timeline

Start date
2014-12-01
Primary completion
2015-12-01
First posted
2015-03-11
Last updated
2015-03-11

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02385370. Inclusion in this directory is not an endorsement.